论文部分内容阅读
目的:探讨应用经尿道前列腺剜除术和经尿道前列腺电切术治疗前列腺增生症的临床疗效及安全性,旨在为规范前列腺增生症的治疗方案提供参考依据。方法:应用随机数字表法从2008年12月～2011年12月我院泌尿外科收治的前列腺增生症患者中选取116例作为研究对象,并将其随机分为对照组(58例)和实验组(58例)两组。对照组患者应用经尿道前列腺电切术进行治疗,实验组患者应用经尿道前列腺剜除术进行治疗。比较两组患者的手术时间、术中出血量、切除前列腺增生腺体的量、术后住院时间、术后并发症发生的情况及术后3个月最大尿流率(Qmax),用来评价经尿道前列腺剜除术和经尿道前列腺电切术治疗前列腺增生症的临床疗效和安全性,并将两组患者的临床资料进行回顾性的分析。结果:实验组患者在手术中的出血量及出现的并发症要明显少于对照组患者(P<0.05),实验组患者的手术时间及术后住院时间明显短于对照组患者(P<0.05),实验组患者切除增生腺体的量明显大于对照组患者(P<0.05),两组患者术后3个月最大尿流率之间的差异无显著性(P>0.05)。结论:采用经尿道前列腺剜除术治疗前列腺增生症的疗效显著,具有术中出血量少、手术时间短、安全高效等优点。此外,采用这种手术能更加彻底地切除前列腺增生的腺体,值得在临床上推广应用。
Objective: To investigate the clinical efficacy and safety of transurethral resection of prostate and transurethral resection of prostate for the treatment of benign prostatic hyperplasia (BPH). The purpose is to provide a reference for regulating the treatment of benign prostatic hyperplasia. Methods: 116 cases of benign prostatic hyperplasia (BPH) treated in Department of Urology from December 2008 to December 2011 in our hospital were randomly divided into control group (58 cases) and experimental group (58 cases) two groups. Patients in the control group were treated with transurethral resection of the prostate and patients in the experimental group were treated with transurethral resection of the prostate. The operation time, intraoperative blood loss, the amount of benign prostatic hyperplasia, the length of postoperative hospital stay, the incidence of postoperative complications and the maximum blood flow rate (Qmax) at 3 months were compared between the two groups to evaluate Transurethral resection of prostate and transurethral resection of prostate in the treatment of benign prostatic hyperplasia clinical efficacy and safety, and clinical data of two groups were retrospectively analyzed. Results: The bleeding volume and complications in the experimental group were significantly less than those in the control group (P <0.05). The operation time and postoperative hospital stay in the experimental group were significantly shorter than those in the control group (P <0.05) ). The number of proliferating glands in the experimental group was significantly larger than that in the control group (P <0.05). There was no significant difference between the two groups in the maximum urinary flow rate at 3 months after operation (P> 0.05). Conclusion: Transurethral resection of prostate gland in the treatment of benign prostatic hyperplasia significant effect, with less blood loss, short operative time, safety and efficiency advantages. In addition, the use of this operation can more completely remove the glands of benign prostatic hyperplasia, it is worth in the clinical application.